

| 1. | verteporfin(Visudyne ) | ||
| 2. | pegaptanib ophthalmic(Macugen ) | ||
| 3. | ranibizumab ophthalmic(Lucentis ) | ||
Top
| |||
|
VERTEPORFIN (VER te PORE fin) is used to treat macular degeneration. It is activated by light. This medication is given, then the eye(s) are treated with a laser light. This is called photodynamic therapy (PDT). This treatment results in a slowing of the disease and helps to maintain vision.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
|
|
Photosensitizing agent activated by low-intensity laser light; synthetic benzoporphyrin derivative.
|
|
RANIBIZUMAB (RA ni BIZ oo mab) is an injectable medicine for the eye. It is used to treat wet macular degeneration. This medicine helps to slow the disease and may help to maintain vision. It is not a cure.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
|
|
Recombinant humanized immunoglobulin G 1 kappa (IgG 1 kappa) monoclonal antibody fragment; a vascular endothelial growth factor A (VEGF-A) antagonist.
|
|
PEGAPTANIB (peg AP ta nib) is a drug that is injected into the eye. It is used to treat macular degeneration. This treatment results in a slowing of the disease and helps to maintain vision. It is not a cure.
This medicine may be used for other purposes; ask your health care provider or pharmacist if you have questions.
|
|
Polyethylene glycol (PEG)-conjugated, modified synthetic RNA oligonucleotide and aptamer; selective vascular endothelial growth factor (VEGF) antagonist.
|